COVID-19 and kidney damage
L.V. Mikhailova, D.O. Sheleg, R.S. Bogachev
Immanuel Kant Baltic Federal University, Medical Institute, Kaliningrad, Russia
The review provides data on the frequency and causes of the onset and development of acute kidney injury (AKI) in COVID-19. The review of the available scientific information regarding the onset and/or progression of chronic kidney disease (CKD) in COVID-19 is presented, and the rare forms of kidney damage that can develop with COVID-19 are discussed in detail. Attention is paid to aspects of etiopathogenesis and clinical picture of kidney damage in COVID-19. When writing the article, the authors globally did not address the issues of treating renal pathology formed during COVID-19, since it is currently mainly reduced, on the one hand, to the treatment of a specific form of kidney disease, and on the other hand, to the treatment of coronavirus infection directly. Understanding the processes of alteration of kidney tissue cells in this disease may help to determine approaches to the prevention of kidney damage and the restoration of kidney function in patients with COVID-19 in the future.
About the Autors
Larisa V. Mikhailova – Cand. Sci. (Med.), Associate Professor at the Department of Therapy, Medical Institute, Immanuel Kant Baltic Federal University, Kaliningrad; e-mail: email@example.com. ORCID: 0000-0001-5070-5955.
Dmitry O. Sheleg – Teaching Assistant at the Department of Therapy, Medical Institute, Immanuel Kant Baltic Federal University, Kaliningrad; e-mail: firstname.lastname@example.org. ORCID: 0000-0003-2931-5383.
Robert S. Bogachev – Dr. Sci. (Med.) iences, Professor, Head of the Department of Therapy, Medical Institute, Immanuel Kant Baltic Federal University, Kaliningrad; e-mail: email@example.com. ORCID: 0000-0002-9651-0018.